HCA Healthcare (HCA) Net Income towards Common Stockholders (2010 - 2026)

HCA Healthcare (HCA) has reported Net Income towards Common Stockholders for 17 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• In Q2 2026, Net Income towards Common Stockholders rose 2.06% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $7.8 billion (up 13.86% YoY), while the FY2025 annual figure was $7.8 billion, up 16.67% from the prior year.
• Net Income towards Common Stockholders climbed to $1.9 billion in Q2 2026 per HCA's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $2.6 billion in Q4 2022 and bottomed at $1.3 billion in Q3 2023.
• Historically, Net Income towards Common Stockholders has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2024.
• On a YoY basis, Net Income towards Common Stockholders climbed as much as 31.97% in 2022 and fell as far as 45.63% in 2022.
• HCA Healthcare's Net Income towards Common Stockholders stood at $2.6 billion in 2022, then retreated by 29.78% to $1.9 billion in 2023, then declined by 9.26% to $1.7 billion in 2024, then climbed by 27.4% to $2.1 billion in 2025, then dropped by 10.15% to $1.9 billion in 2026.
• Business Quant data shows HCA's Net Income towards Common Stockholders at $1.9 billion in Q2 2026, $1.9 billion in Q1 2026, and $2.1 billion in Q4 2025.